Holen Sie sich die Stockscreener-App
8.6996
9.95%
0.8096
Engene Therapeutics Inc Aktie (ENGN) Neueste Nachrichten
Invus-group and Avicenna report 6.7% and 1.1% stakes in enGene (ENGN) - Stock Titan
Piper Sandler reiterates Engene stock rating on clinical data outlook - Investing.com
Piper Sandler Maintains EnGene Therapeutics(ENGN.US) With Buy Rating, Maintains Target Price $26 - Moomoo
enGene Holdings Inc. (NASDAQ:ENGN) Sees Significant Increase in Short Interest - MarketBeat
H.C. Wainwright Keeps Their Buy Rating on enGene Holdings (ENGN) - The Globe and Mail
H.C. Wainwright Maintains EnGene Therapeutics(ENGN.US) With Buy Rating, Maintains Target Price $25 - Moomoo
enGene Announces Expanded $125 Million Debt Facility with Hercules Capital, Inc. - The National Law Review
ENGN | enGene Therapeutics Inc. Common Insider Trading - Quiver Quantitative
WBB Securities initiates coverage of Engene Therapeutics (ENGN) with buy recommendation - MSN
Is enGene (ENGNW) stock facing uncertainty (-5.10%) 2026-04-20Trending Social Stocks - Newser
Wall Street Zen Downgrades enGene (NASDAQ:ENGN) to Sell - MarketBeat
enGene Holdings Inc. (NASDAQ:ENGN) Sees Large Growth in Short Interest - MarketBeat
ENGN Options Volatility — NASDAQ:ENGN - TradingView
WBB Securities Initiates a Buy Rating on enGene Holdings (ENGN) - The Globe and Mail
WBB Securities Initiates EnGene Therapeutics(ENGN.US) With Buy Rating, Announces Target Price $21.5 - Moomoo
ENGN Options Chain — NASDAQ:ENGN - TradingView
Engene Therapeutics Inc. Live Share Prices and Trades. ENGNW.US Live Streaming Share Prices. - London South East
ENGN Initiates Coverage On enGene Therapeutics -- Rating Set to Buy - GuruFocus
Sentiment Watch: Is enGene Holdings Inc Equity Warrant stock a value trap2026 Major Catalysts & Weekly Stock Performance Updates - baoquankhu1.vn
WBB Securities Initiates Coverage on enGene (NASDAQ:ENGN) - MarketBeat
enGene Therapeutics (NASDAQ:ENGN) Stock, Unusual Options - Benzinga
Published on: 2026-04-13 18:10:23 - baoquankhu1.vn
Aug Opening: Will enGene Holdings Inc stock hit new highs in YEAR2026 Support & Resistance & Risk Managed Investment Signals - baoquankhu1.vn
Revenue Check: Is enGene Holdings Inc forming bullish engulfing patterns2026 Risk Factors & High Return Trade Guides - baoquankhu1.vn
EBIT per share of enGene Therapeutics Inc. – FWB:S0N0 - TradingView — Track All Markets
EBITDA margin % of enGene Therapeutics Inc. – FWB:S0N0 - TradingView — Track All Markets
enGene Therapeutics (FRA:S0N0) Cyclically Adjusted PS Ratio : (As of Apr. 16, 2026) - GuruFocus
Cash per share of enGene Therapeutics Inc. – FWB:S0N0 - TradingView
Total liabilities of enGene Therapeutics Inc. – FWB:S0N0 - TradingView
Total liabilities & shareholders' equities of enGene Therapeutics Inc. – FWB:S0N0 - TradingView — Track All Markets
enGene Therapeutics Inc.: Shareholders Board Members Managers and Company Profile | CA29286X1015 - marketscreener.com
S0N0: Static price chart | enGene Therapeutics Inc. | CA29286X1015 - marketscreener.com
enGene Therapeutics Inc. Changes Name and Prepares for 2027 Commercial Launch of Detalimogene Voraplasmid for High-Risk NMIBC - Minichart
enGene Therapeutics Inc.: Fundamental Analysis and Financial Ratings | ENGN | CA29286X1015 - marketscreener.com
ENGN: Static price chart | enGene Therapeutics Inc. | CA29286X1015 - marketscreener.com
enGene Therapeutics Inc.: Target Price Consensus and Analysts Recommendations | ENGN | CA29286X1015 - marketscreener.com
enGene Therapeutics Inc.: Financial Data Forecasts Estimates and Expectations | ENGN | CA29286X1015 - marketscreener.com
enGene Therapeutics Rebrands as Company Nears Commercialization - TipRanks
Detalimogene program drives enGene (ENGN) shift to Therapeutics focus - Stock Titan
Bull Run: What analysts say about enGene Holdings Inc Equity Warrant stockFed Meeting & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Chipmakers Recap: How does enGene Holdings Inc compare to its peers2026 Spike Watch & Free Verified High Yield Trade Plans - baoquankhu1.vn
ENGE HLDGNPV: Shareholders Board Members Managers and Company Profile | CA29286M1059 - marketscreener.com
Is enGene Holdings Inc benefiting from interest rate changes2026 Market Overview & Daily Entry Point Alerts - baoquankhu1.vn
ENGNW Stock Warrant Price and Chart — NASDAQ:ENGNW - TradingView — Track All Markets
Smart Money: Is enGene Holdings Inc Equity Warrant stock a value trapMarket Risk Report & Verified Momentum Stock Watchlist - baoquankhu1.vn
EnGene Holdings Inc. will Change its Name to enGene Therapeutics Inc - marketscreener.com
enGene Therapeutics Announces Name Change Ahead of Potential 2027 Approval - National Today
enGene Announces Name Change to enGene Therapeutics Inc. - PharmiWeb.com
enGene Rebrands as enGene Therapeutics Ahead of Potential 2027 Commercial Launch - TipRanks
enGene Holdings changes name to enGene Therapeutics - Investing.com
enGene announces name change to enGene Therapeutics - TipRanks
Engene Holdings IncTo Change Name To Engene Therapeutics Inc. Effective April 8, 2026 - TradingView — Track All Markets
Three new option listings and three option delistings on April 6th - TipRanks
Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN) - The Globe and Mail
enGene Holdings Inc (ENGN) Income Statement - TradingKey
Wells Fargo Maintains EnGene Holdings(ENGN.US) With Buy Rating, Maintains Target Price $25 - Moomoo
Market Leaders: What analysts say about enGene Holdings Inc Equity Warrant stockDollar Strength & High Accuracy Trade Alerts - baoquankhu1.vn
ENGNW SEC FilingsenGene Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Tangible book value per share of enGene Holdings Inc. – NASDAQ:ENGNW - TradingView
enGene Holdings Inc. (NASDAQ:ENGN) Short Interest Down 25.3% in March - MarketBeat
Bull Run: Why is enGene Holdings Inc Equity Warrant stock going upQuarterly Profit Summary & Daily Entry Point Alerts - baoquankhu1.vn
Setup Watch: What are the analyst revisions for enGene Holdings IncIs FACT stock a good investment in YEARInflation Watch & Community Consensus Trade Alerts - baoquankhu1.vn
0.78%
3.01%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):